- Home
- MEGL vs CHEK Comparison
MEGL vs CHEK Comparison
Compare MEGL & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEGL
- CHEK
- Stock Information
- Founded
- MEGL 2016
- CHEK 2004
- Country
- MEGL Hong Kong
- CHEK Israel
- Employees
- MEGL N/A
- CHEK N/A
- Industry
- MEGL Finance: Consumer Services
- CHEK Medical Electronics
- Sector
- MEGL Finance
- CHEK Health Care
- Exchange
- MEGL Nasdaq
- CHEK Nasdaq
- Market Cap
- MEGL 4.8M
- CHEK 4.0M
- IPO Year
- MEGL 2022
- CHEK 2015
- Fundamental
- Price
- MEGL $1.27
- CHEK $0.67
- Analyst Decision
- MEGL
- CHEK
- Analyst Count
- MEGL 0
- CHEK 0
- Target Price
- MEGL N/A
- CHEK N/A
- AVG Volume (30 Days)
- MEGL 24.6K
- CHEK 22.2K
- Earning Date
- MEGL 05-06-2025
- CHEK 05-14-2025
- Dividend Yield
- MEGL N/A
- CHEK N/A
- EPS Growth
- MEGL N/A
- CHEK N/A
- EPS
- MEGL N/A
- CHEK N/A
- Revenue
- MEGL $1,645,862.00
- CHEK N/A
- Revenue This Year
- MEGL N/A
- CHEK N/A
- Revenue Next Year
- MEGL N/A
- CHEK N/A
- P/E Ratio
- MEGL N/A
- CHEK N/A
- Revenue Growth
- MEGL N/A
- CHEK N/A
- 52 Week Low
- MEGL $0.41
- CHEK $0.56
- 52 Week High
- MEGL $3.06
- CHEK $3.04
- Technical
- Relative Strength Index (RSI)
- MEGL 49.81
- CHEK 41.37
- Support Level
- MEGL $1.12
- CHEK $0.64
- Resistance Level
- MEGL $1.24
- CHEK $0.71
- Average True Range (ATR)
- MEGL 0.13
- CHEK 0.06
- MACD
- MEGL -0.00
- CHEK 0.00
- Stochastic Oscillator
- MEGL 59.52
- CHEK 31.06
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.